Three air travel-related contact investigations associated with infectious tuberculosis, 2007-2008

Travel Medicine and Infectious Disease

Volumn 8, Issue 2, 2010, Pages 120-128

  Kornylo Duong, Krista ^a,f   Kim, Curi ^a   Cramer, Elaine H ^a   Buff, Ann M ^b   Rodriguez Howell, Daniel ^a   Doyle, June ^c   Higashi, Julie ^d   Fruthaler, Carolyn S ^e   Robertson, Carrie L ^e   Marienau, Karen J ^a  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^d Tuberculosis Prevention and Control Program   (United States)

^e Harris County Public Health Environmental Services   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Airplane; Contact tracing; Disease transmission; Multidrug resistant TB; WHO guidelines

Indexed keywords

ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; AVIATION; BACTERIUM CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC TEST; DISEASE TRANSMISSION; FEMALE; FEVER; FOLLOW UP; HEMOPTYSIS; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PNEUMOTHORAX; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPUTUM SMEAR; THORAX RADIOGRAPHY; TRAFFIC SAFETY; TUBERCULOSIS; WEIGHT REDUCTION; ADOLESCENT; AIRCRAFT; CONTACT EXAMINATION; INFECTION CONTROL; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; METHODOLOGY; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; STATISTICS; TRAVEL; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AIRCRAFT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONTACT TRACING; DISEASE NOTIFICATION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GUIDELINES AS TOPIC; HUMANS; LATENT TUBERCULOSIS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TRAVEL; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 77955908879     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2009.08.001     Document Type: Article

References (28)

1. Chemardin J, Paty MC, Renard-Dubois S, Veziris N, Antoine D. Contact tracing of passengers exposed to an extensively drugresistant tuberculosis case during an air flight from Beirut to Paris. Euro Surveill October 2006;2007(12):3325.
2. Buff AM, Scholten D, Rivest P, Hannah H, Marshall J, Wiersma P, et al. Multinational investigation of a traveler with suspected extensively drug-resistant tuberculosisd2007. Poster presented at: 12th Annual North America Region Conference of the International Union Against Tuberculosis and Lung Disease; 2008 Feb 28-Mar 1; San Diego, California.
3. Centers for Disease Control and Prevention. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Morbid. Mortal Wkly Rep 2005; 54(RR12):1-81.
4. Abubakar I, Welfare R, Moore J, Watson J. Surveillance of air travel-related tuberculosis incidents, England and Wales: 2007-2008. Euro Surveill 2008;13(23):1-3.
5. World Health Organization. Tuberculosis and air travel: guidelines for prevention and control. WHO. 2nd ed. Geneva: World Health Organization; 2006 (WHO/HTM/TB/2006.361).
6. World Health Organization. Tuberculosis and air travel: guidelines for prevention and control. WHO. 3rd ed. Geneva: World Health Organization; 2008 (WHO/HTM/TB/2008.399).
7. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and the CDC. MMWR Morbid Mortal Wkly Rep 2005;54(RR15):1-37.
8. Department of Health and Human Services, Public Health Services Act: Quarantine and Inspection Regulations, 42 C.F.R. 70 and 42 C.F.R. 71. Available at URL: http://law.justia.com/us/cfr/title42/42cfrv102.html [accessed 04.22.09].
9. Executive Order 13295: revised list of quarantinable communicable diseases. Fed Register Apr 4 2003;68(68):17244.
10. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON®-Tβ Gold Test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morbid Mortal Wkly Rep 2005;54(RR15):49-55.
11. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
12. World Health Organization. Global tuberculosis control: surveillance, planning, financing. World Health Organization. Geneva: WHO; 2008 (WHO/HTM/TB/2008.393).
13. Menzies D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159:15-21.
14. Wasz-Hockert O. On the period of incubation in tuberculosis. Ann Med Fenn 1947;96:764-72.
15. Wallgren A. The time-table of tuberculosis. Tuberculosis 1948; 29:245-51.
16. Poulsen A. Some clinical features of tuberculosis: I. Incubation period. Acta Tuberc Scand 1950;24:311-46.
17. Department of Health and Human Services. CDC, National Center for HIV, STD, and TB Prevention, Division of Tuberculosis Elimination. Guide for primary health care providers: targeted tuberculin testing and treatment of latent tuberculosis infection. Atlanta: Department of Health and Human Services; 2005.
18. World Health Organization. Stop TB Partnership, Available at URL: http://www.stoptb.org/countries [accessed 05.02.09].
19. Scholten D, Saunders A. Reporting patterns and clinical characteristics of TB cases with history of air travel: the Canadian experience. The International Journal of Tuberculosis and Lung Disease. 39th World Conference of Lung Health of the International Union Against Tuberculosis and Lung Disease; 2008 October 16-20; Paris, France.
20. Whitlock G, Calder L, Perry H. A case of infectious tuberculosis on two long-haul aircraft flights: contact investigation. N Z Med J 2001;114:353-5.
21. Byrne N. Low prevalence of TB on long-haul aircraft. Travel Med Infect Dis 2007;5:18-23.
22. Moore M, Fleming KS, Sands L. A passenger with pulmonary/laryngeal tuberculosis: no evidence of transmission on two short flights. Aviat Space Environ Med 1996;67:1097-100.
23. Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Contact investigations as a means of detection and timely treatment of persons with infectious multidrugresistant tuberculosis. Int J Tuberc Lung Dis 2003;7:S501-9.
24. Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2001;5:321-8.
25. Sneag DB, Schaaf HS, Cotton MF, Zar HJ. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J 2007;26:1142-6.
26. Francis J. Curry National Tuberculosis Center and California Department of Public Health. Drug-resistant tuberculosis: A survival guide for clinicians. 2nd ed. Sacramento, California: California Health and Human Services Agency; 2008.
27. Curtis A, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999;341(20): 1491-5.
28. Reichler MR, Reves R, Bur S, Thompson V, Mangura VT, Ford J, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287:991-5.